For the first time, long-term data show sustained cognitive improvement at one year in patients who have undergone carotid stenting, according to a report from the 2007 International Symposium on Endovascular Therapy.
For the first time, long-term data show sustained cognitive improvement at one year in patients who have undergone carotid stenting, according to a report from the 2007 International Symposium on Endovascular Therapy. What's more interesting is that many asymptomatic patients in the study also showed improved cognitive functions following stenting.
This finding has led investigators to question the very notion of labeling these patients who are asymptomatic. The government currently reimburses only for symptomatic patients undergoing carotid stenting, according to Dr. Rodney Raabe, an interventional radiologist with Inland Vascular Institute in Spokane, WA.
"Symptomatic carotid stenosis may need to be redefined in the future to include functional deficits," Raabe said. "Perhaps potential neurocognitive improvement will be considered in carotid stenosis treatment."
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.